Phase II Study of STA-2 in Patients With Chronic Stable Angina

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Chronic Stable Angina
Interventions
DRUG

STA-2

"After 1 week of screening and washout, patients who met the entry criteria were randomly assigned either to the treatment or control group. The regimen of STA-2 was:~STA-2 250 mg capsule, each containing 100 mg green tea polyphenols, 2 capsules t.i.d. (three times a day) for 6 weeks, to be administered in a non-fasting state."

DRUG

Placebo

"After 1 week of screening and washout, patients who met the entry criteria were randomly assigned either to the treatment or control group. The regimen of Placebo was:~Placebo 250 mg capsule, 2 capsules t.i.d. (three times a day) for 6 weeks, to be administered in a non-fasting state."

Trial Locations (3)

Unknown

Chi Mei Medical Center, Tainan City

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

Sinphar Pharmaceutical Co., Ltd

OTHER

NCT01484912 - Phase II Study of STA-2 in Patients With Chronic Stable Angina | Biotech Hunter | Biotech Hunter